Wells and colleagues showed mesenchymal-like MDA-MB-231 breast cancer cells re-express E-cadherin through loss of methylation in the E-cadherin promoter when the cells reach the secondary organ environment via tail vein injection (Chao et al., 2010). This evidence concerns the gene CDH1 and breast carcinoma.